Rhythm Pharmaceuticals Announces Positive Topline Results from Pivotal Phase 3 Clinical Trials Evaluating Setmelanotide in POMC and LEPR Deficiency Obesities


You May Also Like

National Cancer Institute selects Apexian Pharmaceuticals to participate in the Small Business Innovation Research (SBIR) Initiative program

Indianapolis, Indiana, USA, Sept. 27, 2017 (GLOBE NEWSWIRE) --                                                                                                                                           FOR IMMEDIATE RELEASE National ...